Shares of Health Care sector company Zimmer Biomet moved -1.5% today, and are now trading at a price of $95.46. The Large-Cap stock's daily volume was 1,291,964 compared to its average volume of 2,252,862. The S&P 500 index returned a -0.0% performance.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company is based in Warsaw and has 17,000 full time employees. Its market capitalization is $18,886,569,984. Zimmer Biomet currently offers its equity investors a dividend that yields 1.0% per year.
26 analysts are following Zimmer Biomet and have set target prices ranging from $91.0 to $149.11 per share. On average, they have given the company a rating of hold. At today's prices, ZBH is trading -12.12% away from its average analyst target price of $108.62 per share.
Over the last year, ZBH shares have gone down by -18.6%, which represents a difference of -30.8% when compared to the S&P 500. The stock's 52 week high is $120.13 per share and its 52 week low is $89.92. With average free cash flows of $1.26 Billion that have been growing at an average rate of 0.9% over the last 5 years, Zimmer Biomet declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 1,499,400 | 203,800 | 1,295,600 | 0.4 |
| 2023 | 1,581,600 | 291,100 | 1,290,500 | 10.46 |
| 2022 | 1,356,200 | 187,900 | 1,168,300 | -13.82 |
| 2021 | 1,499,200 | 143,600 | 1,355,600 | 24.07 |
| 2020 | 1,204,500 | 111,900 | 1,092,600 | -21.25 |
| 2019 | 1,585,800 | 198,400 | 1,387,400 |
